| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |